DarioHealthDRIO +7.85%58 Days Inventory is 162.44 as of Mar. 2026, which is 40% above its 10-year median of 116.35. GuruFocus rates DRIO with a GF Score™ of 58/100 and a GF Value™ of $7.09 (Fairly Valued). The stock has 4 warning signs investors should review. Among 495 Healthcare Providers & Services companies, DarioHealth ranks worse than 92.32% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). DarioHealth's Average Total Inventories for the
three
months ended in Mar. 2026 was $4.24 Mil. DarioHealth's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $2.38 Mil.
Hence, DarioHealth's Days Inventory for the
three
months ended in Mar. 2026 was 162.44.
The historical rank and industry rank for DarioHealth's Days Inventory or its related term are showing as below:
DRIO'
s Days Inventory Range Over the Past 10 Years
Min: 80.78 Med: 116.35 Max: 179.08
Current: 179.08
During the past 13 years, DarioHealth's highest Days Inventory was 179.08. The lowest was 80.78. And the median was 116.35.
DRIO's Days Inventory is ranked worse than 92.32% of 495
companies
in the Healthcare Providers & Services industry
Industry Median: 30.42
vs DRIO: 179.08
DarioHealth's Days Inventory
increased
from Mar. 2025 (149.04) to Mar. 2026 (162.44).
It might indicate that DarioHealth's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
DarioHealth's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.56.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
DarioHealth's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.76.
DarioHealth (NAS:DRIO) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
DarioHealth's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
DarioHealth's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
DarioHealth Days Inventory Related Terms
DarioHealth Days Inventory Historical Data
* Premium members only.
The historical data trend for DarioHealth's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DRIO vs BEAT, ONMD, CRVW: Days Inventory Comparison
For the Health Information Services subindustry, DarioHealth's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DarioHealth Days Inventory vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DarioHealth's Days Inventory distribution charts can be found below:
* The bar in red indicates where DarioHealth's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DarioHealth (DRIO) has a Days Inventory of 162.44 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on DarioHealth and its competitors. This is 40% above median its historical median of 116.35. Over the past decade, DarioHealth's Days Inventory has ranged from 80.78 to 179.08. According to the industry distribution chart, DarioHealth ranks #457 out of 495 companies in the Healthcare Providers & Services industry, placing it in the top 92.3%.
Is DarioHealth's Days Inventory too high?
DarioHealth's current Days Inventory of 162.44 is 40% above median its 10-year median of 116.35. Over the past 10 years, this metric has ranged from a low of 80.78 to a high of 179.08. The Healthcare Providers & Services industry median Days Inventory is 30.42. DarioHealth's value of 162.44 is 434% above this industry median. Based on the distribution chart, DarioHealth ranks #457 out of 495 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, DarioHealth has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DarioHealth's Days Inventory compare to BEAT and ONMD?
According to the Healthcare Providers & Services industry distribution chart, DarioHealth ranks #457 out of 495 companies for Days Inventory. This places DarioHealth in the lower half of its industry. The industry median Days Inventory is 30.42. DarioHealth's value of 162.44 is 434% above this benchmark. Historically, DarioHealth's own Days Inventory has ranged from 80.78 to 179.08 over the past decade. While the company's 10-year median is 116.35 vs. the industry median of 30.42, DarioHealth has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 30.42, based on 495 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DarioHealth's current Days Inventory of 162.44 is 434% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on DarioHealth and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 30.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DarioHealth's current Days Inventory is 162.44, which is 40% above median its own 10-year median of 116.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DarioHealth stock overvalued right now?
Based on GuruFocus' analysis, DarioHealth (DRIO) is currently considered Fairly Valued. The stock's GF Value™ is $7.09, compared to a current price of $7.26 — trading 2.3% above its estimated fair value. The current Days Inventory is 162.44, which is 40% above median its 10-year median of 116.35 and 434% above the Healthcare Providers & Services industry median of 30.42. DarioHealth's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For DarioHealth (DRIO), the current Days Inventory is 162.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DarioHealth (DRIO) Overvalued in 2026?
Based on GuruFocus' analysis, DarioHealth stock appears to be overvalued.
The current stock price of $7.26 is trading 2.3% above its estimated GF Value™ of $7.09.
GuruFocus considers DarioHealth to be Fairly Valued.
Key valuation signals for DRIO:
Days Inventory: 162.44 (40% above median its 10-year median of 116.35)
GF Value™: $7.09 vs. price of $7.26 (2.3% above fair value)
Industry Position: 434% above the Healthcare Providers & Services median (#457 of 495)
No single metric tells the full story. See the DRIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
58GF Score
Get the complete analysis for DRIO
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DRIO has been successfully added to your 
